[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Twist Bioscience Corp (TWST)

Twist Bioscience Corp (TWST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,540,106
  • Shares Outstanding, K 62,271
  • Annual Sales, $ 376,570 K
  • Annual Income, $ -77,670 K
  • EBIT $ -135 M
  • EBITDA $ -110 M
  • 60-Month Beta 2.22
  • Price/Sales 9.68
  • Price/Cash Flow N/A
  • Price/Book 8.01

Options Overview Details

View History
  • Implied Volatility 88.88% (+7.33%)
  • Historical Volatility 71.93%
  • IV Percentile 72%
  • IV Rank 52.41%
  • IV High 117.20% on 11/20/25
  • IV Low 57.69% on 08/12/25
  • Expected Move (DTE 6) 4.25 (7.48%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 58
  • Volume Avg (30-Day) 411
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 6,171
  • Open Int (30-Day) 5,260
  • Expected Range 52.60 to 61.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.45
  • Number of Estimates 2
  • High Estimate $-0.42
  • Low Estimate $-0.48
  • Prior Year $-0.47
  • Growth Rate Est. (year over year) +4.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.11 +20.68%
on 04/10/26
66.06 -13.94%
on 04/22/26
+5.68 (+11.10%)
since 04/08/26
3-Month
41.52 +36.92%
on 03/20/26
66.06 -13.94%
on 04/22/26
+7.61 (+15.45%)
since 02/06/26
52-Week
23.30 +143.99%
on 11/14/25
66.06 -13.94%
on 04/22/26
+24.24 (+74.33%)
since 05/08/25

Most Recent Stories

More News
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value biotech company, today announced that a total...

TWST : 56.85 (-2.89%)
Twist Bioscience: Fiscal Q2 Earnings Snapshot

Twist Bioscience: Fiscal Q2 Earnings Snapshot

TWST : 56.85 (-2.89%)
Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences

Synthesis of structurally complex and highly-engineered protein sequences to enable acceptance of approximately 99.5% of clonal gene orders and 99.9% of all DNA products Complex synthesis capabilities...

TWST : 56.85 (-2.89%)
Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the second quarter fiscal 2026 ended March...

TWST : 56.85 (-2.89%)
Twist Bioscience's Path to Breakeven Assumes Everything Goes Right—What If One Thing Doesn't

Barchart Research What to Expect from TWST Earnings TWST Generated May 1, 2026 Current Price $60.40 EPS Estimate $$-0.54 Consensus Rating Strong Buy Average Move 9.38% Twist Bioscience's Path to Breakeven...

TWST : 56.85 (-2.89%)
Twist Bioscience's Path to Breakeven Assumes Everything Goes Right—What If One Thing Doesn't

Barchart Research What to Expect from TWST Earnings TWST Generated May 1, 2026 Current Price $60.40 EPS Estimate $$-0.54 Consensus Rating Strong Buy Average Move 9.38% Twist Bioscience's Path to Breakeven...

TWST : 56.85 (-2.89%)
Twist Bioscience's Path to Breakeven Assumes Everything Goes Right—What If One Thing Doesn't

Barchart Research What to Expect from TWST Earnings TWST Generated May 1, 2026 Current Price $60.40 EPS Estimate $$-0.54 Consensus Rating Strong Buy Average Move 9.38% Twist Bioscience's Path to Breakeven...

TWST : 56.85 (-2.89%)
Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026

Company to host conference call at 8:00 AM ET Investor Day Scheduled for May 21, 2026

TWST : 56.85 (-2.89%)
Twist Bioscience to Present at Upcoming Investor Conferences

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Adam Laponis, CFO of...

TWST : 56.85 (-2.89%)
Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement

B-Body ® platform complements Twist’s antibody discovery offering enabling rapid, efficient and precise expression and discovery of complex bispecific antibody therapeutics ...

TWST : 56.85 (-2.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered...

See More

Key Turning Points

3rd Resistance Point 61.57
2nd Resistance Point 60.28
1st Resistance Point 58.57
Last Price 56.85
1st Support Level 55.57
2nd Support Level 54.28
3rd Support Level 52.57

See More

52-Week High 66.06
Last Price 56.85
Fibonacci 61.8% 49.73
Fibonacci 50% 44.68
Fibonacci 38.2% 39.63
52-Week Low 23.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.